INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

JNJJOHNSON & JOHNSON

CIK 0000200406

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells3 / 9
Max Insider Score30
Connections8with evidence

JNJ · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KSep 30, 2026Oct 30, 2026
traded Sep 30, 2026
+30dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Disclosed trade inevidence
    Lloyd DoggettPurchase disclosed 2026-10-05 · Oct 5, 2026
  • ← Disclosed trade inevidence
    Thomas H. Kean, Jr.Sale disclosed 2026-09-12 · Sep 12, 2026
  • ← Lobbied forevidence
    FORBES-TATELDA RR 2026 third quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
20
Lloyd DoggettDSelf
JNJJOHNSON & JOHNSON
Purchase
BUY
$1,001 – $15K
Sep 8, 2026
Oct 5, 2026
traded Sep 8, 2026
+27d
HOUSE PTR

Evidence

16
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KAug 27, 2026Sep 12, 2026
traded Aug 27, 2026
+16dHOUSE PTR

Evidence

16
RM
Richard Dean McCormickSelf
JNJJOHNSON & JOHNSON
Sale
SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
traded Jul 30, 2026
+15dHOUSE PTR

Evidence

16
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KJun 29, 2026Jul 15, 2026
traded Jun 29, 2026
+16dHOUSE PTR

Evidence

20
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KJun 2, 2026Jul 15, 2026
traded Jun 2, 2026
+43dHOUSE PTR

Evidence

20
Lloyd DoggettDSelf
JNJJOHNSON & JOHNSON
Purchase
BUY$1,001 – $15KJun 9, 2026Jul 6, 2026
traded Jun 9, 2026
+27dHOUSE PTR

Evidence

21
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KMar 26, 2026Apr 13, 2026
traded Mar 26, 2026
+18dHOUSE PTR

Evidence

25
RM
Richard Dean McCormickSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
traded Mar 19, 2026
+19dHOUSE PTR

Evidence

25
RM
Richard Dean McCormickSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KMar 19, 2026Apr 7, 2026
traded Mar 19, 2026
+19dHOUSE PTR

Evidence

24
Lloyd DoggettDSelf
JNJJOHNSON & JOHNSON
Purchase
BUY$1,001 – $15KMar 10, 2026Apr 6, 2026
traded Mar 10, 2026
+27dHOUSE PTR

Evidence

24
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$15K – $50KJan 23, 2026Feb 19, 2026
traded Jan 23, 2026
+27dHOUSE PTR

Evidence

30
ST
Schmid TimothyEVP, WW Chair, MedTech
JNJJOHNSON & JOHNSON
Option exercise
M$1.59M
15.6K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

30
ST
Schmid TimothyEVP, WW Chair, MedTech
JNJJOHNSON & JOHNSON
Tax withholding
F$2.48M
10.3K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

18
ST
Schmid TimothyEVP, WW Chair, MedTech
JNJJOHNSON & JOHNSON
Option exercise
M$1.59M
15.6K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

18
FE
Forminard ElizabethEVP, Chief Legal Officer
JNJJOHNSON & JOHNSON
Option exercise
M$1.16M
8,921 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC FORM 4

Evidence

30
FE
Forminard ElizabethEVP, Chief Legal Officer
JNJJOHNSON & JOHNSON
Tax withholding
F$1.48M
6,226 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC FORM 4

Evidence

30
FE
Forminard ElizabethEVP, Chief Legal Officer
JNJJOHNSON & JOHNSON
Option exercise
M$1.16M
8,921 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    BRICK STREET STRATEGYLDA Q2 2026 second quarter · VET · Aug 26, 2026
  • ← Disclosed trade inevidence
    Richard Dean McCormickSale disclosed 2026-04-07 · Apr 7, 2026
  • ← Insider ofevidence
    Schmid TimothyEVP, WW Chair, MedTech · Feb 10, 2026
  • ← Insider ofevidence
    Forminard ElizabethEVP, Chief Legal Officer · Feb 6, 2026

    • Lobbying

    $60K reported · de-duplicated
    2026 Q3 $0 via firms2026 Q2 $30K via firms2026 Q1 $30K via firms
    • FORBES-TATE—2026 Q3 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • BRICK STREET STRATEGY$30K2026 Q2 · posted Aug 26, 2026 · VET
    • BRICK STREET STRATEGY$30K2026 Q1 · posted Aug 26, 2026 · VET

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.